STEM与日常科技·英语30篇（3）
3 / 30
正在校验访问权限...
mRNA Platforms and Vaccine Iteration Speed
mRNA平台与疫苗迭代速度
-
mRNA vaccines don’t contain live virus—they deliver genetic instructions for making just one harmless viral protein.
-
Once the platform is validated, swapping the mRNA sequence lets scientists build a new vaccine in weeks, not years.
-
During the Omicron surge, updated boosters entered clinical trials just 48 days after the variant’s genome was shared.
-
This speed relies on standardized lipid nanoparticles that safely carry any mRNA payload into human cells.
-
Manufacturing doesn’t require growing viruses in eggs or bioreactors, cutting both time and contamination risk.
-
Regulators now approve updates based on lab data alone—no need to repeat large-scale efficacy trials each time.
-
Future flu shots may refresh annually like software, matching circulating strains with precision and agility.
-
The platform’s flexibility makes it ideal not only for infectious disease but also for personalized cancer vaccines.